Trial intelligence / Profile preview

Botox injection before thumb flexor tendon repair

IRCT20220723055523N1Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Feb 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, single-blind trial of neuronox in thumb flexor tendon injury (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Evaluation of joint movement limitation. Started Feb 2023; status: completed.

02

Drugs

neuronox
03

Conditions

thumb flexor tendon injury

Beyond the preview

Go deeper on IRCT20220723055523N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220723055523N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call